Alembic Pharmaceuticals surged on getting EIR from USFDA for Panelav facility

05 Oct 2016 Evaluate

Alembic Pharmaceuticals is currently trading at Rs. 684.55, up by 24.40 points or 3.70% from its previous closing of Rs. 660.15 on the BSE.

The scrip opened at Rs. 665.00 and has touched a high and low of Rs. 699.50 and Rs. 665.00 respectively. So far 24110 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 747.00 on 07-Oct-2015 and a 52 week low of Rs. 514.35 on 05-Feb-2016.

Last one week high and low of the scrip stood at Rs. 685.00 and Rs. 630.40 respectively. The current market cap of the company is Rs. 12787.03 crore.

The promoters holding in the company stood at 74.13%, while Institutions and Non-Institutions held 13.54% and 12.33% respectively.

Alembic Pharmaceuticals has received Establishment Inspection Report (EIR) from US Food & Drug Administration (USFDA). The regulator had carried out the inspection at the company's formulation facility located at Panelav in March, 2016.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907. The company manufactures and markets generic pharmaceuticals products all over the world.

 

Alembic Pharma Share Price

848.85 2.70 (0.32%)
17-Dec-2025 12:15 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1783.20
Dr. Reddys Lab 1277.65
Cipla 1492.95
Zydus Lifesciences 919.75
Lupin 2115.75
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×